Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Methods in molecular biology (Clifton, N.J.)

There is still an urgent need to develop effective treatments to help minimize the cases of severe COVID-19. A number of tools have now been developed and applied to address these issues, such as the use of non-contrast chest computed tomography (CT) for evaluation and grading of the associated lung damage. Here we used a deep learning approach for predicting the outcome of 1078 patients admitted into the Baqiyatallah Hospital in Tehran, Iran, suffering from COVID-19 infections in the first wave of the pandemic. These were classified into two groups of non-severe and severe cases according to features on their CT scans with accuracies of approximately 0.90. We suggest that incorporation of molecular and/or clinical features, such as multiplex immunoassay or laboratory findings, will increase accuracy and sensitivity of the model for COVID-19 -related predictions.

Sahebkar Amirhossein, Abbasifard Mitra, Chaibakhsh Samira, Guest Paul C, Pourhoseingholi Mohamad Amin, Vahedian-Azimi Amir, Kesharwani Prashant, Jamialahmadi Tannaz

2022

COVID-19, Chest CT, Computed tomography, Deep learning, Diffuse opacities, Lesion distribution, SARS-CoV-2